Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Scott

Showing results (311-320 of 338) with videos related to

Pageof 34
Sort By:
Journal of Clinical Pharmacology|February 28, 2013
Evaluation of the impact of UGT polymorphism on the pharmacokinetics and pharmacodynamics of the novel PPAR agonist sipoglitazarFrances Stringer, Bart A Ploeger, Joost DeJongh, et al.
Optics Express|November 11, 2025
Kinetic inductance and jitter dependence of intrinsic photon-number resolution in superconducting nanowire single-photon detectorsRoland Jaha, Connor A Graham-Scott, Adrian S Abazi, et al.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|June 11, 2015
The setting of nurse staffing levels must be evidence-basedBaroness Emerton, Elizabeth Robb, Katherine Murphy, et al.
Pharmaceutical Research|April 9, 2004
Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphyIan R Wilding, Alyson L Connor, Polly Carpenter, et al.
British Journal of Clinical Pharmacology|July 19, 2012
Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy menGraham Scott, Irfan Ahmad, Katy Howard, et al.
Journal of Clinical Pharmacology|May 18, 2004
Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profileJyoti Kalbag, Cheryl Elder, Graham Scott, et al.
Methods (San Diego, Calif.)|March 11, 2010
Rapid quantification of DNA libraries for next-generation sequencingBernd Buehler, Holly H Hogrefe, Graham Scott, et al.
Clinical Pharmacology and Therapeutics|June 17, 2022
Ziritaxestat Drug-Drug Interaction with Oral Contraceptives: Role of SULT1E1 InhibitionEric Helmer, Negin Karimian, Karen Van Assche, et al.
The Journal of Dermatological Treatment|March 17, 2007
Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 yearEdwin J M Van Leent, Henry J C De Vries, Marie-Eve Ebelin, et al.
Clinical Pharmacokinetics|November 11, 2003
Pharmacokinetics of pimecrolimus, a novel nonsteroid anti-inflammatory drug, after single and multiple oral administrationGraham Scott, Stuart A Osborne, Gerard Greig, et al.
Pageof 34

Showing results (311-320 of 338) with videos related to

Sort By:
Pageof 34
Journal of Clinical Pharmacology|February 28, 2013
Evaluation of the impact of UGT polymorphism on the pharmacokinetics and pharmacodynamics of the novel PPAR agonist sipoglitazarFrances Stringer, Bart A Ploeger, Joost DeJongh, et al.
Optics Express|November 11, 2025
Kinetic inductance and jitter dependence of intrinsic photon-number resolution in superconducting nanowire single-photon detectorsRoland Jaha, Connor A Graham-Scott, Adrian S Abazi, et al.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|June 11, 2015
The setting of nurse staffing levels must be evidence-basedBaroness Emerton, Elizabeth Robb, Katherine Murphy, et al.
Pharmaceutical Research|April 9, 2004
Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphyIan R Wilding, Alyson L Connor, Polly Carpenter, et al.
British Journal of Clinical Pharmacology|July 19, 2012
Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy menGraham Scott, Irfan Ahmad, Katy Howard, et al.
Journal of Clinical Pharmacology|May 18, 2004
Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profileJyoti Kalbag, Cheryl Elder, Graham Scott, et al.
Methods (San Diego, Calif.)|March 11, 2010
Rapid quantification of DNA libraries for next-generation sequencingBernd Buehler, Holly H Hogrefe, Graham Scott, et al.
Clinical Pharmacology and Therapeutics|June 17, 2022
Ziritaxestat Drug-Drug Interaction with Oral Contraceptives: Role of SULT1E1 InhibitionEric Helmer, Negin Karimian, Karen Van Assche, et al.
The Journal of Dermatological Treatment|March 17, 2007
Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 yearEdwin J M Van Leent, Henry J C De Vries, Marie-Eve Ebelin, et al.
Clinical Pharmacokinetics|November 11, 2003
Pharmacokinetics of pimecrolimus, a novel nonsteroid anti-inflammatory drug, after single and multiple oral administrationGraham Scott, Stuart A Osborne, Gerard Greig, et al.
Pageof 34